376 related articles for article (PubMed ID: 18442485)
1. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones.
Wang HH; Portincasa P; Mendez-Sanchez N; Uribe M; Wang DQ
Gastroenterology; 2008 Jun; 134(7):2101-10. PubMed ID: 18442485
[TBL] [Abstract][Full Text] [Related]
2. Ezetimibe prevents the formation of oestrogen-induced cholesterol gallstones in mice.
de Bari O; Wang HH; Portincasa P; Paik CN; Liu M; Wang DQ
Eur J Clin Invest; 2014 Dec; 44(12):1159-68. PubMed ID: 25303682
[TBL] [Abstract][Full Text] [Related]
3. Ezetimibe prevents cholesterol gallstone formation in mice.
Zúñiga S; Molina H; Azocar L; Amigo L; Nervi F; Pimentel F; Jarufe N; Arrese M; Lammert F; Miquel JF
Liver Int; 2008 Aug; 28(7):935-47. PubMed ID: 18783541
[TBL] [Abstract][Full Text] [Related]
4. Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol.
Wang HH; Portincasa P; de Bari O; Liu KJ; Garruti G; Neuschwander-Tetri BA; Wang DQ
Eur J Clin Invest; 2013 Apr; 43(4):413-26. PubMed ID: 23419155
[TBL] [Abstract][Full Text] [Related]
5. LXR driven induction of HDL-cholesterol is independent of intestinal cholesterol absorption and ABCA1 protein expression.
Kannisto K; Gåfvels M; Jiang ZY; Slätis K; Hu X; Jorns C; Steffensen KR; Eggertsen G
Lipids; 2014 Jan; 49(1):71-83. PubMed ID: 24163219
[TBL] [Abstract][Full Text] [Related]
6. The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.
Wang HH; Portincasa P; Wang DQ
Eur J Clin Invest; 2016 Feb; 46(2):158-69. PubMed ID: 26683129
[TBL] [Abstract][Full Text] [Related]
7. Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization.
Uppal H; Zhai Y; Gangopadhyay A; Khadem S; Ren S; Moser JA; Xie W
Hepatology; 2008 Apr; 47(4):1331-42. PubMed ID: 18318438
[TBL] [Abstract][Full Text] [Related]
8. Effect of Inhibition of Intestinal Cholesterol Absorption on the Prevention of Cholesterol Gallstone Formation.
Portincasa P; Wang DQ
Med Chem; 2017; 13(5):421-429. PubMed ID: 28185534
[TBL] [Abstract][Full Text] [Related]
9. Dramatically increased intestinal absorption of cholesterol following hypophysectomy is normalized by thyroid hormone.
Gälman C; Bonde Y; Matasconi M; Angelin B; Rudling M
Gastroenterology; 2008 Apr; 134(4):1127-36. PubMed ID: 18395092
[TBL] [Abstract][Full Text] [Related]
10. Evidence that the adenosine triphosphate-binding cassette G5/G8-independent pathway plays a determinant role in cholesterol gallstone formation in mice.
Wang HH; Li X; Patel SB; Wang DQ
Hepatology; 2016 Sep; 64(3):853-64. PubMed ID: 27014967
[TBL] [Abstract][Full Text] [Related]
11. Hypothyroidism Increases Cholesterol Gallstone Prevalence in Mice by Elevated Hydrophobicity of Primary Bile Acids.
Kube I; Tardio LB; Hofmann U; Ghallab A; Hengstler JG; Führer D; Zwanziger D
Thyroid; 2021 Jun; 31(6):973-984. PubMed ID: 33231505
[No Abstract] [Full Text] [Related]
12. Inhibition of cholesterol absorption by SCH 58053 in the mouse is not mediated via changes in the expression of mRNA for ABCA1, ABCG5, or ABCG8 in the enterocyte.
Repa JJ; Dietschy JM; Turley SD
J Lipid Res; 2002 Nov; 43(11):1864-74. PubMed ID: 12401885
[TBL] [Abstract][Full Text] [Related]
13. Microbiota prevents cholesterol loss from the body by regulating host gene expression in mice.
Zhong CY; Sun WW; Ma Y; Zhu H; Yang P; Wei H; Zeng BH; Zhang Q; Liu Y; Li WX; Chen Y; Yu L; Song ZY
Sci Rep; 2015 May; 5():10512. PubMed ID: 26015368
[TBL] [Abstract][Full Text] [Related]
14. Effect of beta-muricholic acid on the prevention and dissolution of cholesterol gallstones in C57L/J mice.
Wang DQ; Tazuma S
J Lipid Res; 2002 Nov; 43(11):1960-8. PubMed ID: 12401895
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 is not required for murine intestinal cholesterol transport.
Valasek MA; Weng J; Shaul PW; Anderson RG; Repa JJ
J Biol Chem; 2005 Jul; 280(30):28103-9. PubMed ID: 15919660
[TBL] [Abstract][Full Text] [Related]
16. Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine.
Wang HH; Wang DQ
Hepatology; 2005 Oct; 42(4):894-904. PubMed ID: 16175613
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters.
Valasek MA; Repa JJ; Quan G; Dietschy JM; Turley SD
Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G813-22. PubMed ID: 18718997
[TBL] [Abstract][Full Text] [Related]
18. Hepatic Mttp deletion reverses gallstone susceptibility in L-Fabp knockout mice.
Xie Y; Fung HY; Newberry EP; Kennedy S; Luo J; Crooke RM; Graham MJ; Davidson NO
J Lipid Res; 2014 Mar; 55(3):540-8. PubMed ID: 24474819
[TBL] [Abstract][Full Text] [Related]
19. Augmented cholesterol absorption and sarcolemmal sterol enrichment slow small intestinal transit in mice, contributing to cholesterol cholelithogenesis.
Xie M; Kotecha VR; Andrade JD; Fox JG; Carey MC
J Physiol; 2012 Apr; 590(8):1811-24. PubMed ID: 22331417
[TBL] [Abstract][Full Text] [Related]
20. Physical chemistry of intestinal absorption of biliary cholesterol in mice.
Wang DQ; Lee SP
Hepatology; 2008 Jul; 48(1):177-85. PubMed ID: 18506855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
